Frontiers in Oncology · 2021 · 26 citations · 31 references
MedicineMolecular BiologyOncologyMetastasisMolecular OncologyTumor ProgressionBone MetastasisCancer ProgressionMalignant NeoplasmsMicrorna-mediated RegulationNoncoding Rna BiologyNoncoding Rna In CancerCancer-related Noncoding Rna FunctionLong Noncoding Rna RegulationMicrorna Function In CancerMicrorna In CancerNoncoding Rna In MetastasisRna SequencingRna Sequencing (Rna-seq)Tumor Cell Proliferation
Osteosarcoma (OS), a type of malignant bone tumor, is commonly found in children and adolescents. Although previous studies have identified that long non-coding RNAs (lncRNAs) regulate OS, it is unclear whether lncRNAs impact the progression of OS. Here, we identified LINC00607 , a lncRNA that facilitates OS proliferation, migration, and invasion. Based on the RNA-sequencing results, LINC00607 expression was significantly upregulated in pulmonary metastasis within OS. Functional experiments revealed that LINC00607 promoted migration and invasion of endothelial cells to exacerbate epithelial-mesenchymal transition (EMT). Furthermore, the results of RNA pull-down assay and invasion assay suggested that the binding between LINC00607 and miR-607 promoted OS invasion. Bioinformatic analysis and rescue experiments demonstrated that E2F6 , a transcriptional factor, functioned downstream of LINC00607 /miR-607. Finally, we found that LINC00607 promoted OS progression in vivo . This work revealed that LINC00607 worked as an miR-607 sponge to upregulate E2F6 expression, which promoted tumor proliferation in OS. These results identified a novel therapeutic target for treating OS.
31
Stefan Bielack, Beate Kempf‐Bielack, G. Delling et al. · Journal of Clinical Oncology · 2002 · 1.8K citations